Navigation Links
A small cut with a big impact
Date:5/2/2012

Diseases and injuries trigger warning signals in our cells. As a result, genes are expressed and proteins produced, modified or degraded to adapt to the external danger and to protect the organism. In order to be able to produce a particular protein, the corresponding DNA segment, the gene, needs to be expressed and translated. The DNA is localized in the cell nucleus, and exists as a long string that is coiled and bound by proteins. ARTD1 is one such protein, and therefore has the potential to regulate the expression level of genes through its interaction with DNA.

If cells detect warning signals or foreign bodies like bacteria and viruses in their surroundings, the expression profile of genes changes and an inflammatory response is triggered. To induce changes in gene expression, ARTD1 is removed from particular sites of the DNA. The process by which this is brought about has, until now, remained elusive. The team headed by Professor Michael O. Hottiger from the Institute of Veterinary Biochemistry and Molecular Biology at the University of Zurich has now discovered how ARTD1's DNA recruitment is regulated during inflammation, thereby influencing gene expression and subsequently inflammation.

Molecular scissors

As the researchers demonstrate in Molecular Cell, ARTD1 is cut into two pieces by molecular scissors, the protein caspase 7. Upon cleavage, these pieces can no longer bind to the DNA, thus allowing for more efficient gene expression.

The cleavage of proteins by caspase 7 was so far mainly associated with cell death. "The cleavage of ARTD1 by caspase 7 during inflammation constitutes a new biological function. It permits a new understanding of inflammatory responses and, in the longer term, may lead to the development of new anti-inflammatory drugs," explains Professor Hottiger. The results are of considerable importance because inflammation underlies most diseases, including cancer, immune disorders or metabolic syndrome.


'/>"/>

Contact: Michael Hottiger
hottiger@vetbio.uzh.ch
41-446-355-477
University of Zurich
Source:Eurekalert

Related biology news :

1. Laparoscopy reduces the risk of small-bowel obstruction
2. New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
3. Turning off small RNA
4. Smallest tools could give biggest results in bone repair
5. New species of tiny frog is worlds smallest vertebrate
6. Members of small monkey groups more likely to fight
7. A small step for lungfish, a big step for the evolution of walking
8. Worlds smallest frogs discovered in New Guinea
9. Big pest, small genome
10. Scripps research scientists develop brand new class of small molecules through innovative chemistry
11. CO2 bonds in sea ice: Small living creatures with major impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/29/2019)... (PRWEB) , ... October 29, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced that Octapharma, one ... Bioprocess® platform to support the development and manufacturing of therapeutic proteins ...
(Date:10/26/2019)... , ... October 23, 2019 , ... ... a bioceramic nanotube surface that demonstrated the FDA requirements for nanotechnology. , ... of nanotechnology. This nanotechnology plays an important role in achieving Nanovis’ goal to ...
(Date:10/26/2019)... ... October 25, 2019 , ... Leak Detection Associates ... the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is excited to announce ... the SIMS Model 1915+ . The SIMS 1915+ unit is engineered incorporating industry-leading ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 10, 2019 , ... ... of clinical research centers in Europe. All Pratia research centers have completed VirTrial’s ... become trained and certified as Virtual Trial Capable and prepared to conduct decentralized ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia Corporation, the ... (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) has granted ... the temporary relief of chronic neck and shoulder pain of musculoskeletal origin. , ...
(Date:10/3/2019)... ... October 01, 2019 , ... ... reset itself, announced the midway point of its randomized research trial for individuals ... is to measure the efficacy of a non-invasive technology which compares tones delivered ...
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked the official launch ... clinical program outsourcing success by cultivating radical improvements in leadership, staff, and broader ... Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in the intricacies ...
Breaking Biology Technology: